Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 21, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for March 9, 2002 Subscribe to this News Feed      
 

Compounds in Tea may be able to replace protease inhibitors as a treatment for AIDS

Both caffeine and polyphenols from tea can have a dramatic effect in reducing the ability of the HIV virus to replicate and spread throughout the body.

IMMEDIATE RELEASE
March 9, 2002
Contact Dr. Stephen Martin
01-707-996-6081
grouppekurosawa@grouppekurosawa.com

Compounds in Tea May Be Able to Replace Protease Inhibitors as a Treatment For AIDS

Grouppe Kurosawa has published some essays on its web site on the use of powerful plant derived compounds as viable treatments for both HIV infections and cancer. It invites the public to read these essays.

Caffeine reduces the synthesis of the HIV virus in T cells by 94%. Polyphenols in green and black tea powerfully inhibit an enzyme complex called the proteasome. The proteasome is also an inadvertent target of HIV protease inhibitors; the inhibition of a key enzyme in this complex can completely account for the therapeutic properties of the current group of HIV protease inhibitors on the market. In one of their essays, Grouppe Kurosawa cites evidence that over 99.9% of HIV viruses isolated from volunteers in different stages of disease are already dead. If HIV protease inhibitors only inhibited the viral protease, as intended, these drugs would be therapeutically worthless. The inhibition of the proteasome by anti-HIV drugs was not anticipated by the pharmaceutical companies that developed them. It was a stroke of good fortune. Proteasome inhibitors interfere with the budding, maturation and infectivity of HIV. They also destroy virally infected cells, thereby drastically reducing the level of virus in the body. Unfortunately, the long-term use of these drugs leads to diabetes, hypertension, disorders in cholesterol and fat metabolism and a suppressed immune system.

According to Dr. Stephen Martin, Chief Scientist of Grouppe Kurosawa, hundreds of important scientific studies have been published on HIV and cancer that are never brought to the attention of the public. The caffeine study is a case in point. Youd think that if a simple compound like caffeine could reduce the synthesis of HIV by 94%, there would be some mention in the national news. Scientists conduct research and publish their results in scientific journals, documents not read by the public. They do not hold press conferences or otherwise call attention to their work. We dont have these constraints. If polyphenols in tea can inhibit the proteasome complex to the same extent as expensive, toxic synthetic drugs, we believe the public should be informed. It seems ridiculous to assert that a simple compound in tea might help control HIV; on the other hand, it seems equally absurd that a compound in tree bark, quinine, could kill the malaria parasite. But it does. Grouppe Kurosawa is attempting to bridge the large gap between the scientific community and the public. We are going to continue writing scientific essays on the use of natural medicines as treatments for acute and chronic disease. Perhaps someone will listen."

The URL that contains these essays on HIV is found at http://www.grouppekurosawa.com/hiv.html.

END

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Dr. Stephen Martin
Grouppe Kurosawa
01-707-996-6081
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright